Acurx Pharmaceuticals(ACXP) - 2024 Q2 - Quarterly Results

Exhibit 99.1 For Immediate Release — 7:01 am ET on Friday, August 9, 2024 Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update Staten Island, NY, August 9, 2024 — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the second quarter ended June 30, 2024. Highli ...